These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36910023)

  • 1. An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases.
    Ding S; Liu B; Zheng S; Wang D; Liu M; Liu H; Zhang P; Peng K; He H; Zhou R; Guo J; Qiu B; Huang X; Liu H
    Clin Transl Radiat Oncol; 2023 May; 40():100602. PubMed ID: 36910023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study.
    Wang B; Liu Y; Zhang J; Yin S; Liu B; Ding S; Qiu B; Deng X
    J Neurooncol; 2024 Mar; 167(1):123-132. PubMed ID: 38300388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct dosimetric comparison of linear accelerator vs. Gamma Knife fractionated stereotactic radiotherapy (fSRT) of large brain tumors.
    Calugaru E; Whiting Z; Delacruz B; Ma D; Garcia B; Goenka A; Chang J
    Med Dosim; 2023 Spring; 48(1):31-36. PubMed ID: 36503990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
    Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
    Adair Smith G; Dunlop A; Alexander SE; Barnes H; Casey F; Chick J; Gunapala R; Herbert T; Lawes R; Mason SA; Mitchell A; Mohajer J; Murray J; Nill S; Patel P; Pathmanathan A; Sritharan K; Sundahl N; Tree AC; Westley R; Williams B; McNair HA
    Radiother Oncol; 2023 Mar; 180():109457. PubMed ID: 36608770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique.
    Ruggieri R; Naccarato S; Mazzola R; Ricchetti F; Corradini S; Fiorentino A; Alongi F
    Radiat Oncol; 2018 Mar; 13(1):38. PubMed ID: 29506539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
    Boekhoff MR; Bouwmans R; Doornaert PAH; Intven MPW; Lagendijk JJW; van Lier ALHMW; Rasing MJA; van de Ven S; Meijer GJ; Mook S
    Clin Transl Radiat Oncol; 2022 May; 34():82-89. PubMed ID: 35372703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases.
    Weykamp F; Katsigiannopulos E; Piskorski L; Regnery S; Hoegen P; Ristau J; Renkamp CK; Liermann J; Forster T; Lang K; König L; Rippke C; Buchele C; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
    Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
    Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.
    Brennan VS; Burleson S; Kostrzewa C; Godoy Scripes P; Subashi E; Zhang Z; Tyagi N; Zelefsky MJ
    Radiother Oncol; 2023 Feb; 179():109441. PubMed ID: 36549340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer.
    Hawranko R; Sohn JJ; Neiderer K; Bump E; Harris T; Fields EC; Weiss E; Song WY
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Evaluation of a Novel Cone-Beam CT-Based Semi-Automated Online Adaptive Radiotherapy System for Head and Neck Cancer Treatment - A Timing and Automation Quality Study.
    Yoon SW; Lin H; Alonso-Basanta M; Anderson N; Apinorasethkul O; Cooper K; Dong L; Kempsey B; Marcel J; Metz J; Scheuermann R; Li T
    Cureus; 2020 Aug; 12(8):e9660. PubMed ID: 32923257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.
    Soisson ET; Tomé WA; Richards GM; Mehta MP
    Radiother Oncol; 2006 Mar; 78(3):313-21. PubMed ID: 16490269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-fraction dynamics during post-operative 5 fraction cavity hypofractionated stereotactic radiotherapy with a MR LINAC: a prospective serial imaging study.
    Tan H; Stewart J; Ruschin M; Wang MH; Myrehaug S; Tseng CL; Detsky J; Husain Z; Chen H; Sahgal A; Soliman H
    J Neurooncol; 2022 Feb; 156(3):569-577. PubMed ID: 34981300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer.
    Mittauer KE; Yarlagadda S; Bryant JM; Bassiri N; Romaguera T; Gomez AG; Herrera R; Kotecha R; Mehta MP; Gutierrez AN; Chuong MD
    Radiother Oncol; 2023 Nov; 188():109869. PubMed ID: 37657726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.